Canada markets closed

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
24.52-0.54 (-2.15%)
At close: 04:00PM EDT
25.00 +0.48 (+1.96%)
After hours: 06:13PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.55B
Enterprise Value 2.14B
Trailing P/E 23.35
Forward P/E 34.25
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.17
Price/Book (mrq)4.66
Enterprise Value/Revenue 4.44
Enterprise Value/EBITDA 19.54

Trading Information

Stock Price History

Beta (5Y Monthly) 0.48
52-Week Change 35.47%
S&P500 52-Week Change 322.38%
52 Week High 334.28
52 Week Low 320.84
50-Day Moving Average 323.88
200-Day Moving Average 326.59

Share Statistics

Avg Vol (3 month) 31.1M
Avg Vol (10 day) 31.62M
Shares Outstanding 5104.11M
Implied Shares Outstanding 6104.11M
Float 885.31M
% Held by Insiders 111.38%
% Held by Institutions 184.82%
Shares Short (Apr 15, 2024) 421.12M
Short Ratio (Apr 15, 2024) 424.85
Short % of Float (Apr 15, 2024) 428.67%
Short % of Shares Outstanding (Apr 15, 2024) 420.34%
Shares Short (prior month Mar 15, 2024) 420.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 22.54%
Operating Margin (ttm)20.09%

Management Effectiveness

Return on Assets (ttm)11.96%
Return on Equity (ttm)21.91%

Income Statement

Revenue (ttm)523.53M
Revenue Per Share (ttm)5.12
Quarterly Revenue Growth (yoy)39.00%
Gross Profit (ttm)N/A
EBITDA 122.8M
Net Income Avi to Common (ttm)117.2M
Diluted EPS (ttm)1.05
Quarterly Earnings Growth (yoy)74.80%

Balance Sheet

Total Cash (mrq)410.76M
Total Cash Per Share (mrq)3.94
Total Debt (mrq)76k
Total Debt/Equity (mrq)0.01%
Current Ratio (mrq)5.18
Book Value Per Share (mrq)5.27

Cash Flow Statement

Operating Cash Flow (ttm)124.84M
Levered Free Cash Flow (ttm)123.86M